5.221 makale bulundu

Correction: Zhang et al. Caudate-Centric Triphasic Network Reconfiguration Characterizes the Early Progression of Cognitive Impairment in Parkinson's Disease: A Simultaneous PET/fMRI Study. Journal of Integrative Neuroscience. 2026; 25(2): 46634.

Zhang W, Li G, Mao F, Zhao H, Zhao L, Liang L, Guo Y, Sun C, Yang Y, Wang X, Luo X.

J Integr Neurosci · 2026-06-01

DOI: 10.31083/jin55311PMID: 42411442

KGT: Knowledge-guided graph transformer for neurodegenerative disease diagnosis and brain age prediction with MRI.

Zhao J, Ding R, Liu M.

Med Image Anal · 2026-06-01

DOI: 10.1016/j.media.2026.104143PMID: 42242081

A survey of deep learning techniques in detecting neurological disorders using MRI.

Mane D, Bidwe R, Shetty R, Shinde A, Shende G, Sharma V.

Biomed Eng Online · 2026-05-29

DOI: 10.1186/s12938-026-01587-6PMID: 42216001

Superior dorsal nigral hyperintensity depiction at 7 T MRI using CLEAR-DESS improves diagnosis performance of Parkinson's disease.

Li S, Chen R, Li Q, Hsu Y, He J, Su Y, Wang D, Zhou H, Zhang W, Meng L, Liu S, Tang J, Li C, Lei P, Qian L, Qu J, Xing W, Bai HX, Liao W.

NPJ Parkinsons Dis · 2026-05-28

DOI: 10.1038/s41531-026-01415-7PMID: 42209516

Fenotipten biyolojiye: Parkinson hastalığında biyoakışkan, doku, görüntüleme ve dijital biyobelirteçlerin multimodal yol haritası.

From phenotype to biology: a multi-modal roadmap of biofluid, tissue, imaging, and digital biomarkers in Parkinson's disease.

Yu Z, Su D, Li S, Lin S, Ren K, Feng T.

Transl Neurodegener · 2026-05-28

DOI: 10.1186/s40035-026-00558-0PMID: 42210437

Age-related changes to brain energetics revealed by PET/MRI imaging.

Bevington CWJ, Dhaliwal S, McKenzie J, Stoessl AJ, Sossi V.

Neuroimage Clin · 2026-05-27

DOI: 10.1016/j.nicl.2026.104014PMID: 42217474

Hastaya özgü 7 Tesla MRI bağlantı analizine dayanan hedefleme, Parkinson hastalığı için derin beyin uyarımını geliştirir.

Targeting based on patient-specific 7 Tesla MRI connectivity analysis improves deep brain stimulation for Parkinson's disease.

Wiggerts Y, Schuurman R, de Bie RMA, Beudel M, van der Zwaag W, van den Munckhof P, Bot M.

NPJ Parkinsons Dis · 2026-05-27

DOI: 10.1038/s41531-026-01414-8PMID: 42204158

In-vivo iron mapping in patients with Parkinson's disease using deep learning-based susceptibility source separation MRI.

Shin HG, Mills KA, Dawson TM, Kim T, Lee J, Li X, van Zijl P, Prasuhn J.

NPJ Parkinsons Dis · 2026-05-27

DOI: 10.1038/s41531-026-01384-xPMID: 42204172

Multispectral 7 Tesla MRI as a potential predictor of dopamine transporter deficiency in Parkinson's disease.

Özer M, Egger B, Mennecke A, Nagel A, Zaiss M, Laun FB, Dörfler A, Winkler J, German A.

Imaging Neurosci (Camb) · 2026-05-26

DOI: 10.1162/imag.a.1241PMID: 42212222

Comparison of neuromelanin-sensitive magnetic resonance imaging using different magnetic resonance protocols on the same patients with Parkinson's disease.

Hirose R, Matsuura K, Ii Y, Kajikawa H, Maeda M, Umino M, Tabei KI, Nishigaki A, Horie S, Ishikawa H, Kagawa K, Shindo A.

J Neural Transm (Vienna) · 2026-05-26

DOI: 10.1007/s00702-026-03179-zPMID: 42191915

Multiparametric MRI and imaging transcriptomics reveal molecular and cellular correlates of neurodegeneration in experimental Parkinsonism.

Kim E, Cash D, Martins D, Simmons C, Heras-Garvin A, Klippel E, Krismer F, Mantoan Ritter L, Stefanova N.

NPJ Parkinsons Dis · 2026-05-25

DOI: 10.1038/s41531-026-01393-wPMID: 42185343

Gray Matter Microstructure Measured Using Diffusion Imaging as a Biomarker of Severity in Lewy Body Diseases.

Zarkali A, Dobreva I, Hannaway N, Bhome R, Thomas GEC, Carrera S, Heslegrave AJ, Veleva E, Zetterberg H, Weil RS.

Mov Disord · 2026-05-25

DOI: 10.1002/mds.70355PMID: 42185748